Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
6.88
0.00 (0.00%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Inogen Market Cap
Inogen has a market cap or net worth of $183.37 million as of April 17, 2025. Its market cap has increased by 13.26% in one year.
Market Cap
183.37M
Enterprise Value
88.98M
1-Year Change
13.26%
Ranking
Category
Stock Price
$6.88
Market Cap Chart
Since February 14, 2014, Inogen's market cap has decreased from $274.90M to $183.37M, a decrease of -33.30%. That is a compound annual growth rate of -3.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 180.90M | -17.17% |
| Dec 31, 2024 | 218.40M | 70.63% |
| Dec 29, 2023 | 128.00M | -71.67% |
| Dec 30, 2022 | 451.80M | -41.52% |
| Dec 31, 2021 | 772.60M | -21.82% |
| Dec 31, 2020 | 988.20M | -34.26% |
| Dec 31, 2019 | 1.50B | -43.75% |
| Dec 31, 2018 | 2.67B | 7.54% |
| Dec 29, 2017 | 2.49B | 82.61% |
| Dec 30, 2016 | 1.36B | 72.72% |
| Dec 31, 2015 | 787.90M | 34.82% |
| Dec 31, 2014 | 584.40M | 112.59% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.49B |
| UnitedHealth Group | 538.21B |
| Johnson & Johnson | 370.96B |
| AbbVie | 311.95B |
| Novo Nordisk | 286.28B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 210.97B |
| Novartis AG | 209.02B |